Legal & General to Sell U.S. Protection Business in $2.3 Billion Deal
The insurance company expects to return an extra $1.24 billion to shareholders via buybacks upon completion of the sale.
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...